Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Position AS
AS
Active
Org 998795699
Lundvegen 35A, 7089
Heimdal
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2012 · 13 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Position AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
1M
1M
1M
0M
0M
2020: 1M
1M
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
EBITDA
NOK millions
1M
1M
1M
0M
0M
2020: 1M
1M
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
428
573
1 004
1 087
854
Staff expenses
−5
−0
−0
−0
−0
EBITDA
176
304
803
882
662
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
176
304
803
882
662
Net financials
−1
−1
0
0
0
Profit before tax
175
303
803
882
662
Tax
39
67
177
194
146
Net profit
136
236
626
688
516
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
2 901
2 786
2 632
2 233
1 513
Equity
2 786
2 661
2 425
1 799
1 111
Long-term debt
0
0
0
0
0
Short-term debt
115
125
207
434
402
Total debt
115
125
207
434
402
Financial ratios
5-year trend
EBITDA margin
41,1 %
This company
15,8 %
Market median
This company
Market median
160% above market
2020
2024
Equity ratio
96,0 %
This company
38,2 %
Market median
This company
Market median
151% above market
2020
2024
Return on equity
4,9 %
This company
18,4 %
Market median
This company
Market median
73% below market
2020
2024
Net profit margin
31,7 %
This company
8,1 %
Market median
This company
Market median
291% above market
2020
2024
Asset turnover
0,15×
This company
1,12×
Market median
This company
Market median
87% below market
2020
2024
Debt / equity
0,04×
This company
0,62×
Market median
This company
Market median
94% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Position AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
